首页> 外文OA文献 >PP189—A Physiologically-Based Mechanistic Pharmacokinetic Model to Assess the Metabolism of Oxycodone in Healthy Volunteers: Interplay Between CYP3A and 2D6 Inhibition

【2h】

PP189—A Physiologically-Based Mechanistic Pharmacokinetic Model to Assess the Metabolism of Oxycodone in Healthy Volunteers: Interplay Between CYP3A and 2D6 Inhibition

机译：PP189 —一种基于生理学的机制药代动力学模型，用于评估健康志愿者中羟考酮的代谢：CYP3A和2D6抑制之间的相互作用

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Marsousi N.; Daali Y.; Humphries H.; Almond L.; Dayer P.; Desmeules J.; Samer C.;
展开▼
作者单位

展开▼
年度 2013
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
专利

1. A mechanistic pharmacokinetic model to assess modified oral drug bioavailability post bariatric surgery in morbidly obese patients: Interplay between CYP3A gut wall metabolism, permeability and dissolution [J] . DarwichA.S., PadeD., AmmoriB.J., Journal of Pharmacy and Pharmacology . 2012,第7期

机译：评估肥胖病患者减肥手术后口服药物生物利用度改善的机制药代动力学模型：CYP3A肠壁代谢，通透性和溶出度之间的相互作用
2. A mechanistic pharmacokinetic model to assess modified oral drug bioavailability post bariatric surgery in morbidly obese patients: Interplay between CYP3A gut wall metabolism, permeability and dissolution [J] . DarwichA.S., PadeD., AmmoriB.J., Journal of Pharmacy and Pharmacology . 2012,第7期

机译：一种机制药代动力学模型，评估改良口腔药物生物利用度在病态肥胖患者中的牛肝外科：CYP3A肠壁代谢，渗透性和溶解之间的相互作用
3. Effects of Strong CYP2C8 or CYP3A Inhibition and CYP3A Induction on the Pharmacokinetics of Brigatinib, an Oral Anaplastic Lymphoma Kinase Inhibitor, in Healthy Volunteers [J] . Tugnait Meera, Gupta Neeraj, Hanley Michael J., Clinical pharmacology in drug development . 2020,第2期

机译：强CYP2C8或CYP3A抑制和CYP3A诱导对Brigatinib的药代动力学，口腔血管性淋巴瘤激酶抑制剂，健康志愿者的影响
4. Pharmacokinetic model for the inhibition of simvastatin metabolism by itraconazole [C] . Lohitnavy Manupat, Methaneethorn Janthima, Chiang-Ngernthanyakool Rangsimaporn, Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2015

机译：伊曲康唑抑制辛伐他汀代谢的药代动力学模型
5. Comparative studies of midazolam metabolism in chickens, turkeys, ring-necked pheasant and bobwhite quail: In vitro, in vivo and physiologically-based pharmacokinetic modeling. [D] . Cortright, Kristy Anne. 2009

机译：鸡肉，火鸡，环颈野鸡和短吻鹌鹑中咪达唑仑代谢的比较研究：体外，体内和基于生理的药代动力学模型。
6. Prediction of Metabolic Interactions With Oxycodone via CYP2D6 and CYP3A Inhibition Using a Physiologically Based Pharmacokinetic Model [O] . N Marsousi, Y Daali, S Rudaz, 2014

机译：基于生理学的药代动力学模型预测通过CYP2D6和CYP3A抑制作用与羟考酮的代谢相互作用
7. Effects of Strong CYP2C8 or CYP3A Inhibition and CYP3A Induction on the Pharmacokinetics of Brigatinib, an Oral Anaplastic Lymphoma Kinase Inhibitor, in Healthy Volunteers [O] . Meera Tugnait, Neeraj Gupta, Michael J. Hanley, 2019

机译：强CYP2C8或CYP3A抑制和CYP3A诱导对Brigatinib的药代动力学，口腔血管性淋巴瘤激酶抑制剂，健康志愿者的影响

PP189—A Physiologically-Based Mechanistic Pharmacokinetic Model to Assess the Metabolism of Oxycodone in Healthy Volunteers: Interplay Between CYP3A and 2D6 Inhibition

著录项

引文网络

相似文献

相关主题

期刊订阅